BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11788681)

  • 1. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy.
    Smith TJ; Koumas L; Gagnon A; Bell A; Sempowski GD; Phipps RP; Sorisky A
    J Clin Endocrinol Metab; 2002 Jan; 87(1):385-92. PubMed ID: 11788681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts.
    Valyasevi RW; Harteneck DA; Dutton CM; Bahn RS
    J Clin Endocrinol Metab; 2002 May; 87(5):2352-8. PubMed ID: 11994387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts.
    Smith TJ; Sempowski GD; Wang HS; Del Vecchio PJ; Lippe SD; Phipps RP
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2620-5. PubMed ID: 7673404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.
    Khoo TK; Coenen MJ; Schiefer AR; Kumar S; Bahn RS
    Thyroid; 2008 Dec; 18(12):1291-6. PubMed ID: 18976167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture.
    Sorisky A; Pardasani D; Gagnon A; Smith TJ
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3428-31. PubMed ID: 8784110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor-gamma gene expression in orbital adipose/connective tissues is increased during the active stage of Graves' ophthalmopathy.
    Mimura LY; Villares SM; Monteiro ML; Guazzelli IC; Bloise W
    Thyroid; 2003 Sep; 13(9):845-50. PubMed ID: 14588098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy.
    Bahn RS; Dutton CM; Natt N; Joba W; Spitzweg C; Heufelder AE
    J Clin Endocrinol Metab; 1998 Mar; 83(3):998-1002. PubMed ID: 9506762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid-associated eye disease.
    Heufelder AE; Joba W
    Strabismus; 2000 Jun; 8(2):101-11. PubMed ID: 10980691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes.
    Koumas L; Smith TJ; Phipps RP
    Eur J Immunol; 2002 Feb; 32(2):477-85. PubMed ID: 11813166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of ophthalmopathy in autoimmune thyroid disease.
    Heufelder AE
    Rev Endocr Metab Disord; 2000 Jan; 1(1-2):87-95. PubMed ID: 11704996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique properties of orbital connective tissue underlie its involvement in Graves' disease.
    Smith TJ
    Minerva Endocrinol; 2003 Sep; 28(3):213-22. PubMed ID: 14605603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
    Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The study of CD90 expressing in orbital fibroblasts of thyroid associated ophthalmopathy].
    Tang L; Luo QL; Xia QJ; Chen QY; Liu CL; Tang J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):879-81. PubMed ID: 17243294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy.
    Kumar S; Coenen MJ; Scherer PE; Bahn RS
    J Clin Endocrinol Metab; 2004 Feb; 89(2):930-5. PubMed ID: 14764816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes.
    Koumas L; Smith TJ; Feldon S; Blumberg N; Phipps RP
    Am J Pathol; 2003 Oct; 163(4):1291-300. PubMed ID: 14507638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue.
    Spitzweg C; Joba W; Hunt N; Heufelder AE
    Eur J Endocrinol; 1997 Jun; 136(6):599-607. PubMed ID: 9225723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate increases the expression of high mobility group AT-hook 2 (HMGA2) gene and induces adipocyte differentiation of orbital fibroblasts from Graves' ophthalmopathy.
    Pasquali D; Pierantoni GM; Fusco A; Staibano S; Colantuoni V; De Bellis A; Bellastella A; Sinisi AA
    J Mol Endocrinol; 2004 Aug; 33(1):133-43. PubMed ID: 15291748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of leptin expression in orbital preadipocyte fibroblasts.
    Erickson DZ; Harteneck DA; Erickson BJ; Dutton CM; Bahn RS
    Thyroid; 2001 Mar; 11(3):221-6. PubMed ID: 11327612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts.
    Korducki JM; Loftus SJ; Bahn RS
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):2037-42. PubMed ID: 1582808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use?
    Starkey K; Heufelder A; Baker G; Joba W; Evans M; Davies S; Ludgate M
    J Clin Endocrinol Metab; 2003 Jan; 88(1):55-9. PubMed ID: 12519830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.